Mary Ziping Luo

Mary Ziping Luo

Chief Operating Officer, Chief Scientist and ChairmanatAmphastar Pharmaceuticals· In proxies 2021–2025

Pay in FY2022+12% from the year before · Amphastar Pharmaceuticals stock +20.3% the same year

Mary Ziping Luo was paid $3.8M in FY2022 (Dec), up 12%. Amphastar Pharmaceuticals stock rose 20.3% that year.

Pay$100 in the stock at the end of FY20 → $139
Pay is from the Summary Compensation Table of each Amphastar Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Amphastar PharmaceuticalsPublic company · 5 yr
    • Chief Operating Officer, Chief Scientist and Chairman2021 – Present · 5 yrStock in role +38%

Roles come from the proxy statements of each company.

Boards1

  • Amphastar PharmaceuticalsChair · 29 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?